{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CLRB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:52:26.711Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":484,"canonical_name":"Cellectar Biosciences, Inc.","cik":"0001279704","uei":null,"lei":null,"duns":null,"ticker":"CLRB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"clinical":1,"sec":31},"count":32,"timeline":[{"ts":"2026-08-14","kind":"clinical.trial","reporter":"Cellectar Biosciences, Inc.","title":"Evaluation of Iopofosine I 131 vs. R-CD in WM Patients","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07766421","excerpt":"[\"Waldenstrom Macroglobulinaemia\",\"Waldenstrom Macroglobulinemia\",\"Waldenstrom's Macroglobulinaemia Refractory\",\"Waldenstrom Macroglobulinemia With Nodal Disease\",\"Waldenstrom's Macroglobulinemia Recurrent\"]","importance":60},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cellectar Biosciences, Inc. — 2026-08-14","url_slug":"/sec/cik-0001279704/schedule-13g/0001104659-26-096752","accession_number":"0001104659-26-096752","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cellectar Biosciences, Inc. — 2026-08-14","url_slug":"/sec/cik-0001279704/schedule-13g/0001104659-26-096766","accession_number":"0001104659-26-096766","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cellectar Biosciences, Inc. — 2026-08-14","url_slug":"/sec/cik-0001279704/schedule-13g/0001727492-26-000017","accession_number":"0001727492-26-000017","importance":55},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cellectar Biosciences, Inc. — 2026-08-13","url_slug":"/sec/cik-0001279704/schedule-13g/0001420506-26-001621","accession_number":"0001420506-26-001621","importance":55},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Cellectar Biosciences, Inc. — 2026-08-13","url_slug":"/sec/cik-0001279704/10-q/0001104659-26-095426","accession_number":"0001104659-26-095426","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Cellectar Biosciences, Inc. — 2026-08-13","url_slug":"/sec/cik-0001279704/8-k/0001104659-26-095460","accession_number":"0001104659-26-095460","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cellectar Biosciences, Inc. — 2026-08-04","url_slug":"/sec/cik-0001279704/schedule-13g/0000919574-26-004748","accession_number":"0000919574-26-004748","importance":55},{"ts":"2026-07-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Cellectar Biosciences, Inc. — 2026-07-10","url_slug":"/sec/cik-0001279704/8-k/0001104659-26-082719","accession_number":"0001104659-26-082719","importance":35},{"ts":"2026-07-10","kind":"sec.filing","form_type":"4/A","title":"4/A — Cellectar Biosciences, Inc. — 2026-07-10","url_slug":"/sec/cik-0001279704/4-a/0001104659-26-082761","accession_number":"0001104659-26-082761","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — Cellectar Biosciences, Inc. — 2026-07-08","url_slug":"/sec/cik-0001279704/4/0001104659-26-082009","accession_number":"0001104659-26-082009","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — Cellectar Biosciences, Inc. — 2026-07-08","url_slug":"/sec/cik-0001279704/4/0001104659-26-082011","accession_number":"0001104659-26-082011","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — Cellectar Biosciences, Inc. — 2026-07-08","url_slug":"/sec/cik-0001279704/4/0001104659-26-082012","accession_number":"0001104659-26-082012","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — Cellectar Biosciences, Inc. — 2026-07-08","url_slug":"/sec/cik-0001279704/4/0001104659-26-082013","accession_number":"0001104659-26-082013","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — Cellectar Biosciences, Inc. — 2026-07-08","url_slug":"/sec/cik-0001279704/4/0001104659-26-082015","accession_number":"0001104659-26-082015","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — Cellectar Biosciences, Inc. — 2026-07-08","url_slug":"/sec/cik-0001279704/4/0001104659-26-082018","accession_number":"0001104659-26-082018","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"3","title":"3 — Cellectar Biosciences, Inc. — 2026-06-09","url_slug":"/sec/cik-0001279704/3/0001104659-26-071893","accession_number":"0001104659-26-071893","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cellectar Biosciences, Inc. — 2026-06-05","url_slug":"/sec/cik-0001279704/schedule-13g/0001274173-26-000157","accession_number":"0001274173-26-000157","importance":55},{"ts":"2026-06-02","kind":"sec.filing","form_type":"424B3","title":"424B3 — Cellectar Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001279704/424b3/0001104659-26-069146","accession_number":"0001104659-26-069146","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Cellectar Biosciences, Inc. — 2026-06-01","url_slug":"/sec/cik-0001279704/effect/9999999995-26-001826","accession_number":"9999999995-26-001826","importance":30},{"ts":"2026-05-29","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Cellectar Biosciences, Inc. — 2026-05-29","url_slug":"/sec/cik-0001279704/corresp/0001104659-26-067935","accession_number":"0001104659-26-067935","importance":30},{"ts":"2026-05-22","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Cellectar Biosciences, Inc. — 2026-05-22","url_slug":"/sec/cik-0001279704/upload/0000000000-26-005261","accession_number":"0000000000-26-005261","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"S-1","title":"S-1 — Cellectar Biosciences, Inc. — 2026-05-19","url_slug":"/sec/cik-0001279704/s-1/0001104659-26-063918","accession_number":"0001104659-26-063918","importance":65},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Cellectar Biosciences, Inc. — 2026-05-18","url_slug":"/sec/cik-0001279704/8-k/0001104659-26-063202","accession_number":"0001104659-26-063202","importance":35},{"ts":"2026-05-18","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Cellectar Biosciences, Inc. — 2026-05-18","url_slug":"/sec/cik-0001279704/pre-14a/0001104659-26-063259","accession_number":"0001104659-26-063259","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Cellectar Biosciences, Inc. — 2026-05-14","url_slug":"/sec/cik-0001279704/10-q/0001104659-26-060678","accession_number":"0001104659-26-060678","importance":45},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Cellectar Biosciences, Inc. — 2026-05-14","url_slug":"/sec/cik-0001279704/8-k/0001104659-26-060693","accession_number":"0001104659-26-060693","importance":35},{"ts":"2026-05-11","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Cellectar Biosciences, Inc. — 2026-05-11","url_slug":"/sec/cik-0001279704/schedule-13g/0000935836-26-000240","accession_number":"0000935836-26-000240","importance":55},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — Cellectar Biosciences, Inc. — 2026-05-11","url_slug":"/sec/cik-0001279704/4/0001104659-26-058854","accession_number":"0001104659-26-058854","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Cellectar Biosciences, Inc. — 2026-05-08","url_slug":"/sec/cik-0001279704/8-k/0001104659-26-057460","accession_number":"0001104659-26-057460","importance":35},{"ts":"2026-05-07","kind":"sec.insider.p","reporter":"CARUSO JAMES V","title":"Chief Executive Officer","shares":8680,"price_per_share":2.88,"usd_value":24998,"security_title":"Common Stock","importance":50.0249984},{"ts":"2026-05-07","kind":"sec.insider.p","reporter":"Longcor Jarrod","title":"Chief Operating Officer","shares":8680,"price_per_share":2.88,"usd_value":24998,"security_title":"Common Stock","importance":50.0249984}]}